Vor to participate in the 11th annual svb leerink global healthcare conference

Cambridge, mass., feb. 11, 2022 (globe newswire) -- vor biopharma (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that dr. robert ang, vor's president and chief executive officer, will present virtually at the 11th annual svb leerink global healthcare conference.

VOR Ratings Summary

VOR Quant Ranking